Bazanov Daniil Romanovich

Academic degree：PhD

Specialty： Organic Chemistry

e-mail：daniil_bazanov@mail.ru

1、Personal profile

My work is devoted to the synthesis and study of various properties of heterocyclic compounds, in particular, imidazolines and imidazoles. I am studying the synthesis of biologically active molecules based on the above-mentioned structures and their anticorrosive activity. I show possible ways of using these structures as precursors in organic chemistry, for example, vicial diamines.

2、Educational experience

2010 – 2015 Faculty of Chemistry, Lomonosov Moscow State University (Moscow, Russia) - Specialist in Medicinal Chemistry

2015– 2019 Faculty of Chemistry, Lomonosov Moscow State University (Moscow, Russia) – PhD student in Organic and Medicinal Chemistry

3、Work experience

2018– now Faculty of Chemistry, Lomonosov Moscow State University (Moscow, Russia) - junior research assistant

4、Selected papers (in last 5 years)

1.  Bazanov, D.R.; Lozinskaya, N.A. Diastereoselective Synthesis of Meso-1,2-Diarylethane-1,2-Diamines Via Sodium Reduction of Imidazolines. Asian Journal of Organic Chemistry 2024, n/a, e202400305, doi:10.1002/ajoc.202400305.

2.  Bazanov, D.R.; Avdeev, Y.G.; Lozinskaya, N.A.; Andreeva, T.E.; Kuznetsov, Y.I. Alkylphenyl-Substituted Imidazolines as Corrosion Inhibitors: Experimental and DFT Study. Mendeleev Communications 2024, 34, 751–754, doi:10.1016/j.mencom.2024.09.041.

3.  Bazanov, D.R.; Savitskaya, V.Yu.; Maximova, N.A.; Tyurin, V.Yu.; Gracheva, Y.A.; Chesnokova, N.B.; Beznos, O.V.; Sosonyuk, S.E.; Lozinskaya, N.A. Antioxidant Activity and Redox Properties of Cis-2,4,5-Tris(Hydroxyaryl)Imidazolines. Mendeleev Communications 2022, 32, 680–682, doi:10.1016/j.mencom.2022.09.038.

4.  Bazanov, D.R.; Pervushin, N.V.; Savin, E.V.; Tsymliakov, M.D.; Maksutova, A.I.; Savitskaya, V.Y.; Sosonyuk, S.E.; Gracheva, Y.A.; Seliverstov, M.Y.; Lozinskaya, N.A.; et al. Synthetic Design and Biological Evaluation of New P53-MDM2 Interaction Inhibitors Based on Imidazoline Core. Pharmaceuticals 2022, 15, 444, doi:10.3390/PH15040444.

5.  Bazanov, D.R.; Pervushin, N.V.; Savin, E.V.; Tsymliakov, M.D.; Maksutova, A.I.; Sosonyuk, S.E.; Kopeina, G.S.; Lozinskaya, N.A. Sulfonamide Derivatives of Cis-Imidazolines as Potent P53-MDM2/MDMX Protein-Protein Interaction Inhibitors. Medicinal Chemistry Research 2021, 30, 2216–2227, doi:10.1007/S00044-021-02802-W/FIGURES/6.